minor stroke/a small stroke in the left parietal region of the brain, tiny but visible; Have to use a cane or a walker; right leg gave up; patient fell on the floor; difficulty with balance because of their right leg; difficulty with walking because of their right leg; This spontaneous case was reported by a consumer and describes the occurrence of CEREBROVASCULAR ACCIDENT (minor stroke/a small stroke in the left parietal region of the brain, tiny but visible) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Fall (Patient had a fall in November 2020 and broke their shoulder) in November 2020 and Broken hand (Patient had a fall in November 2020 and broke their shoulder) in November 2020. Concomitant products included FISH OIL, MAGNESIUM, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), FISH OIL (OMEGA XL), LEVOTHYROXINE SODIUM (LEVOTHYROXINE [LEVOTHYROXINE SODIUM]), DILTIAZEM, LISINOPRIL and ROSUVASTATIN for an unknown indication.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced CEREBROVASCULAR ACCIDENT (minor stroke/a small stroke in the left parietal region of the brain, tiny but visible) (seriousness criteria hospitalization and medically significant), MUSCULAR WEAKNESS (right leg gave up), FALL (patient fell on the floor), BALANCE DISORDER (difficulty with balance because of their right leg) and GAIT DISTURBANCE (difficulty with walking because of their right leg). On an unknown date, the patient experienced WALKING AID USER (Have to use a cane or a walker). The patient was hospitalized from 28-Jan-2021 to 29-Jan-2021 due to CEREBROVASCULAR ACCIDENT. The patient was treated with ACETYLSALICYLIC ACID, ASCORBIC ACID (ASPIRIN [ACETYLSALICYLIC ACID;ASCORBIC ACID]) for Adverse event, at a dose of UNK, qd. At the time of the report, CEREBROVASCULAR ACCIDENT (minor stroke/a small stroke in the left parietal region of the brain, tiny but visible), MUSCULAR WEAKNESS (right leg gave up) and FALL (patient fell on the floor) outcome was unknown and BALANCE DISORDER (difficulty with balance because of their right leg), GAIT DISTURBANCE (difficulty with walking because of their right leg) and WALKING AID USER (Have to use a cane or a walker) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Magnetic resonance imaging: small stroke in the left parietal region of the br (abnormal) Small stroke in the left parietal region of the brain, tiny but visible.         Additional concomitant medications included vit-asid for macular degeneration.  Company comment: This case concerns an 81-year-old female hospitalized with a serious unexpected event of cerebrovascular accident, and nonserious muscular weakness, fall, balance disorder, gait disturbance, and walking aid user. Event latency 18 days after second dose mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: This case concerns an 81-year-old female hospitalized with a serious unexpected event of cerebrovascular accident, and nonserious muscular weakness, fall, balance disorder, gait disturbance, and walking aid user. Event latency 18 days after second dose mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.